值得注意的是，作为热门赛道，今年以来储能领域的港股公司上市首日普遍受到投资者追捧。例如，宁 德时代（300750.SZ）（03750.HK）上市首日涨幅超过16%，双登股份（06960.HK）上涨逾30%，更早 前上市的正力新能（03677.HK）首日也录得上涨。 根据配发结果公告，果下科技本次共发行3893.08万股H股，其中香港公开发售部分为338.53万股，发行 价为每股20.1港元。此次IPO净募集资金约7亿港元，公司计划将资金用于提升研发能力和扩大产能等方 面。 本次发行获得了投资者的热烈响应。在香港公开发售部分，公司获得约1890.73倍的认购，共接获约16.1 万份有效申请，受理申请数目约2.67万份。 在全球能源转型浪潮加速的背景下，储能行业正迎来前所未有的黄金发展期。主打"AI+储能"概念的果 下科技（02655.HK），成功吸引了市场的广泛关注。 12月16日上市首日，果下科技股价表现强劲，盘中大幅上涨。截至发稿，涨幅已达117.91%，成交额 2.45亿港元，市值升至221.98亿港元。以每手100股计算，不计手续费，投资者一手可赚超过2300港元。 此外，公司本次发行还获得了惠开香港、 ...

果下科技 (02655.HK)今日上市，盘初涨89.05%，日前公布称其获1890.73倍认购，每股定价20.1港元， 一手中签率10%。 ...

Core Viewpoint - Guoxia Technology officially listed on the Hong Kong Stock Exchange with a strong debut, opening at HKD 38, a significant increase of 89.05% from the issue price of HKD 20.10 [2][4] Group 1: Stock Performance - The stock opened at HKD 38, with a trading volume of 3.7086 million shares and a total transaction value of HKD 1.32 billion on the first day [2][3] - The stock price reached a high of HKD 38, with a market capitalization of HKD 19.258 billion and a price-to-earnings ratio (TTM) of 218.39 [3] - Prior to the official listing, the stock was traded at HKD 37.88 in the dark market, reflecting an increase of 88.46% from the issue price [4] Group 2: Company Overview - Guoxia Technology is a provider of renewable energy solutions and products in China's energy storage industry, focusing on energy storage system solutions for power generation, grid, and commercial and residential applications [4] - The company is recognized as one of the early participants in integrating energy storage systems with internet cloud services and developing digital energy management platforms [4] - Revenue growth has been explosive, increasing from RMB 142 million in 2022 to RMB 1.026 billion in 2024, representing a compound annual growth rate of 168.9% [4] - Gross profit also saw significant growth, rising from RMB 35.6 million to RMB 155 million during the same period [4] Group 3: Market Demand - The public offering phase saw an overwhelming subscription rate of approximately 1,890.73 times, indicating strong market demand for Guoxia Technology's shares [4]

客户端 果下科技今日正式登陆港交所主板，首日表现强劲。该股开盘报38港元，较发行价20.10港元大幅高开 89.05%，成交额达1.32亿港元。不计手续费，每手100股可赚1790港元。 | 02655 果下科技 | | | | --- | --- | --- | | 38.0001+17.900 +89.05% | | 等待开盘 12/16 09:20 | | * 72 日 = | | ● 快捷交易 | | 最高价 38.000 | 开盘价 38.000 | 成交量 370.86万 | | 曼低价 38.000 | 昨收价 20.100 | 成交额 1.32亿 | | 平均价 35.687 | | 市盈率TTM 218.39 总市值 192.58亿 (m) | | 振 幅 -- | 市盈率(静) 358.49 | 总股本 5.07亿 | | 换手率 0.97% | 市净率 58.641 | 流通值 145.83亿 | | 52周景高 38,000 | 委 比 -20.00% | 流通股 3.84亿 | | 52周最低 38.000 | 量 比 -- | 每 手 100股 | | 历史最高 38.000 | ...

此次公司香港公开发售获1890.73倍认购，国际发售获3.63倍认购。 果下科技公布全球发售配发结果。公司全球发售约3893.08万股H股，其中香港公开发售占8.7%，国际 发售占91.3%。发售价定为每股20.1港元，每手买卖单位为100股H股，H股将于2025年12月16日(星期二) 上午九时开始在联交所买卖。 ...

Group 1: Medical Isotope Production - China National Nuclear Corporation (CNNC) has successfully developed a complete technology chain for the irradiation preparation of iodine-131, enhancing the self-sufficiency of medical isotopes in China [1] - The technology includes the preparation of precursor isotopes, reactor irradiation, and nuclear drug development, forming an environmentally friendly and autonomous industrial chain [1] - The successful production of high-purity tellurium-130 isotopes with over 99% abundance fills a gap in the domestic large-scale preparation of high-purity enriched tellurium isotopes [1] Group 2: Radiation Therapy Equipment and Drug Development - As of 2024, over 90 radiotherapy devices have been approved by the National Medical Products Administration, with more than 70% being domestic brands, significantly reducing reliance on imported equipment [2] - The development of new radiopharmaceuticals has accelerated, with over 200 pipelines entering clinical trials, introducing new isotopes like lutetium-177 and yttrium-90 for more precise cancer treatment options [2] Group 3: Corporate Transactions and Financial Updates - WuXi AppTec has completed the sale of its subsidiary, expecting a post-tax net profit of approximately 960 million yuan, which accounts for over 10% of the company's latest audited net profit attributable to shareholders [5][6] - Guolian Minsheng has terminated a 480 million yuan fund establishment transaction, with no adverse effects on the company's finances or shareholder rights [7] - Morning Paper Industry plans to sell all shares of a target company for 3.336 billion yuan [10] Group 4: New Technologies and Innovations - GAC Group's flying car, GOVY AirCab, has entered the airworthiness certification stage and is expected to be mass-produced by 2026, aiming to create a new mode of transportation that integrates air and ground travel [17] - China Tongyuan has signed a commercial cooperation agreement with Novartis for the radiopharmaceutical product, providing a new treatment option for advanced prostate cancer patients [18]

今日果下科技(2655.HK)上市，翰思艾泰-B(3378.HK)、轻松健康(2661.HK)、诺比侃(2635.HK)、华芢生 物-B(2396.HK)、明基医院(2581.HK)、南华期货股份(2691.HK)、印象大红袍(2695.HK)、智汇矿业 (2546.HK)、希迪智驾(3881.HK)申购。 本文源自：金融界AI电报 ...

New IPOs - Guoxia Technology (02655) received a subscription rate of 1890.73 times for its public offering in Hong Kong, with a share price of HKD 20.1 [1] - Easy Health (02661), Hansai Aitai-B (03378), and Nobi Kan (02635) are scheduled for public offerings from December 15 to December 18, with expected listing on December 23 [1] Major Events - Luoyang Molybdenum (03993) plans to acquire three major gold mining assets in Brazil for USD 1.015 billion [1] - Zhongwei New Materials (02579) has been included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect securities list [1] - Botai Carlink (02889) received a first project confirmation notice from a leading domestic new energy vehicle client [1] - Xiehe New Energy (00182) intends to sell 100% equity of Cangzhou Julong for CNY 65.3 million [1] - Fosun Pharma (02196) plans to invest a total of CNY 1.412 billion to gain control of Green Valley Pharmaceutical [1] - Youqu Holdings (02177) intends to spend JPY 2.701 billion to acquire the Japanese consulting pharmacy chain Akahige [1] Financial Data - China Metallurgical Group (01618) signed new contracts worth CNY 958.13 billion in the first 11 months, a decrease of 8.6% year-on-year [1] - Xinhua Insurance (01336) reported a cumulative original insurance premium income of CNY 188.85 billion in the first 11 months, an increase of 16% year-on-year [1] - China Southern Airlines (01055) saw a 10.42% year-on-year increase in passenger turnover in November [1] - China Shenhua (01088) reported coal sales of 389.5 million tons in the first 11 months, a decrease of 7.7% year-on-year [1] - China Eastern Airlines (00670) experienced a 10.35% year-on-year increase in passenger turnover in November [1] - Air China (00753) reported a 10.1% year-on-year increase in passenger turnover in November [1] Share Buybacks - Tencent Holdings (00700) repurchased 1.051 million shares for HKD 636 million on December 15 [2] - Xiaomi Group-W (01810) repurchased 7.2 million shares for HKD 302 million on December 15 [2] - Geely Automobile (00175) repurchased 1.991 million shares for HKD 34.7485 million on December 15 [2] - Kuaishou-W (01024) repurchased 462,000 shares for HKD 29.9304 million on December 15 [2] - Rongchang Bio (09995) plans to repurchase shares worth between CNY 2 million and CNY 4 million [2] - Gendyn New Drug (01952) received over HKD 38 million in share purchases from directors and major shareholders [2]

其中，香港公开发售获1890.73倍认购，国际发售获3.63倍认购。 果下科技(02655)公布配发结果，公司全球发售约3893.08股H股，香港公开发售占8.7%，国际发售占 91.3%。每股发售价20.1港元，全球发售净筹7.01亿港元。每手100股H股，预期H股将于2025年12月16 日(星期二)上午九时正开始在联交所买卖。 ...

格隆汇12月15日丨果下科技(02655.HK)公告，公司全球发售38,930,800股H股，每股H股20.1港元，所得 款项净额7亿港元。香港公开发售股份数目占全球发售股份数目8.70%，获认购1890.73倍；国际发售股 份数目占全球发售股份91.30%，获认购倍3.63倍。 假设全球发售于2025年12月16日(星期二)上午八时正(香港时间)或之前成为无条件，预期H股将于2025 年12月16日(星期二)上午九时正在联交所开始买卖。H股的每手买卖单位为100股H股，H股的股份代号 为2655。 ...